Nabsys Nabsys to Take Another Shot at Commercializing Electronic Genome Mapping Technology Next Year Premium The Providence, Rhode Island-based firm plans to release its electronic genome mapping technology for human genome applications. Nabsys Raises Additional $13M From Hitachi High-Technologies Providence, Rhode Island-based Nabsys said the additional funding was a result of a technical milestone for its high-definition genome mapping platform. Nabsys Secures up to $38M in Equity Financing From Hitachi High-Tech The electronic genome mapping company said it will initially receive $25 million and can get an additional $13 million upon achieving certain milestones. Genome In a Bottle Consortium Releases Structural Variant Calling Benchmark Data Premium The public-private partnership has published a paper on a list of indels larger than 50 bp that is already being used to develop new methods. Nabsys Raises $21M in Round Led by Hitachi High-Technologies The company plans to use the funding to finish developing and commercially launch its HD-Mapping whole-genome electronic mapping platform. May 24, 2017 Nabsys Aims to Commercialize Genome Mapping Instrument Next Year Premium Oct 12, 2016 Nabsys Generates First Electronic Long-Range Human Genome Maps to Test Structural Variant Calling Premium Mar 31, 2016 Following Financial Restructuring, Nabsys Resurfaces With Much of Original Leadership Team Sep 14, 2015 Report: Nabsys Shuts Down Jan 20, 2015 Nabsys Using DNA Mapping Tech in 'Collaborative Mode'; Eyes Cancer Structural Variant Panels Premium Jan 12, 2015 Nabsys, Ariana Pharmaceuticals Collaborate to ID Structural Variants Linked to Cancer Nov 11, 2014 IP Roundup: NabSys, IMDx, Affymetrix, and Illumina Win US Patents Premium Nov 4, 2014 With New Management, Nabsys Shifts Focus to Cancer Structural Variation Analysis Premium Oct 29, 2014 People in the News: Jeffrey Leiden, Anthony Shuber Premium Oct 28, 2014 Paired Ends: Anthony Shuber, Greg Lucier, Craig Tuttle Premium Oct 14, 2014 IP Roundup: Affymetrix, Nabsys, Ohio State U, Fujirebio Win US Patents Premium Feb 25, 2014 Nabsys to Commercialize Electronic DNA Mapping Platform in 2014; Shows Data at AGBT Premium Mar 13, 2013 Nabsys Raises $20M in Private Financing Round Jan 15, 2013 Nabsys to Launch First Version of Sequencing System this Year for Genome Mapping Applications Premium Jan 17, 2012 Nabsys Develops 'Positional Sequencing' Tech for Assembly, Whole-Genome Mapping, Targeted Sequencing Premium Jan 10, 2012 Nabsys Prepares to Commercialize Nanodetector 'Positional Sequencing' Tech Premium Jan 10, 2012 Paired Ends: Marc Stapley, Stan Rose, Michael Hunkapiller, Jeffrey Sklar, Martin Tolar Premium Jan 3, 2012 Desktop Sequencers Take Center Stage in 2011 as Platform Providers Face Tough Times Premium Sep 20, 2011 Nabsys Raises $10M for Development of its Semiconductor-Based Sequencing System Premium Sep 14, 2011 Sequencing Technology Firm Nabsys Raises $10M in Series C Round Load More Breaking News GA4GH Announces 10 New 'Driver' Projects, Including First Pediatric Partner Single-Cell MRD Assay Helps Characterize Cells Surviving Acute Myeloid Leukemia Therapy Research Triangle Institute Partners With GeneDx, Illumina for Expanded Newborn Screening Study Bionano Genomics' Third Chinese OEM Partner Gets NMPA Nod for Sample Prep Product InformedDNA Buys gWell Health, Names New CEO The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.